Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
02/2005
02/02/2005EP0741788B1 Inducing tolerance with tolerogenic fusion proteins
02/02/2005CN1575337A Mammalian receptor proteins; related reagents and methods
02/02/2005CN1575334A Pathogen for bacterial poultry disease
02/02/2005CN1572878A Method for producing L-amino acid
02/02/2005CN1572872A Method for the recombinant production of polypeptides
02/02/2005CN1572868A Method for producing target substance
02/02/2005CN1572867A Anti-fouling composition and method of production thereof
02/02/2005CN1572729A Microbe decomposition treatment method for waste water and mixing apparatus for waste water treatment agent
02/02/2005CN1572322A Attenuated live neospora vaccine
02/02/2005CN1187451C Method of making proteins in transformed yeast cells
02/02/2005CN1187448C 1, 3-propanediol dehydrogenase Mutant
02/02/2005CN1187446C Process for producing purine nucleosides via fermentation and the microorganism using
02/02/2005CN1187443C Alkaline fungus serine proteinase and its preapring method and application
02/02/2005CN1187440C Method for separating, identifying, purifying, heterotrophying and nitrifying microbe
02/02/2005CN1187439C Biological toxin for preventig and controlling pine nematode and its prepn
02/02/2005CN1187438C Fungus strain for high yield chitinase and use thereof
02/02/2005CN1187374C Humanized antibody specific for human 4-1BB and pharmaceutical compsn comprising same
02/02/2005CN1187371C Method for preparing phycocyanin of sea water
02/01/2005US6849782 Arabidopsis antisense deoxyhypusine synthase molecule and method of inhibiting deoxyhypusine synthase expression in plants
02/01/2005US6849718 Muteins of hypoxia inducible factor alpha and methods of use thereof
02/01/2005US6849447 Protective recombinant Haemophilus influenzae high molecular weight proteins
02/01/2005US6849446 Genetic engineering
02/01/2005US6849444 Rhizopus for use in generation of lactic acids
02/01/2005US6849442 Nucleotide sequence encoding an operon protein, which operon protein is the regulator protein of the R.corallina ohp operon
02/01/2005US6849440 Proteases from gram-positive organisms
02/01/2005US6849436 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders, gout, kidney stones, Lesch-Nyhan syndrome, renal failure and uricaciduria
02/01/2005US6849434 Ethanol production in recombinant hosts
02/01/2005US6849427 Dermatophagoides pteronyssinus proteins
02/01/2005US6849421 Nucleotide sequences coding enzymatic polypeptide for the use in the treatment of nervous system disorders
02/01/2005US6849413 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders
02/01/2005US6849405 Incorporated into expression vectors to enhance recombinant protein production
02/01/2005US6849395 Gene cluster screening of clones having DNA from mixed populations of organisms
02/01/2005US6849279 Glycoprotein; solvent extraction; prevention pollution, ultraviolet radiation damage
02/01/2005US6849261 CD4-independent HIV envelope proteins as vaccines and therapeutics
02/01/2005CA2325351C Non-stochastic generation of genetic vaccines and enzymes
01/2005
01/27/2005WO2005007895A1 Methods and kits for obtaining nucleic acid from biological samples
01/27/2005WO2005007867A2 Thermostable amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof
01/27/2005WO2005007858A1 Plasmid having a function of t-vector and expression vector, and expression of the target gene using the same
01/27/2005WO2005007848A1 Process for producing l-histidine with the use of bacterium belonging to enterobacteriaceae
01/27/2005WO2005007847A1 Process for producing l-glutamic acid
01/27/2005WO2005007845A2 Transgenic cells
01/27/2005WO2005007841A1 Variant serine acetyltransferase and process for producing l-cysteine
01/27/2005WO2005007834A1 Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus
01/27/2005WO2005007833A1 Bacillus strain isolate with fungal suppression activity
01/27/2005WO2005007832A2 System for external control of oncolytic virus replication
01/27/2005WO2005007826A2 Production of aromatic carotenoids in gram negative bacteria
01/27/2005WO2005007818A2 Exo-specific amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof
01/27/2005WO2005007686A1 Rna binding peptide
01/27/2005WO2005006838A2 Flat panel photobioreactor
01/27/2005WO2004099425A3 Pyruvate producing yeast strain
01/27/2005WO2004092334A3 Methods of producing edible fungi containing activated folates and nutritional supplements containing activated folates
01/27/2005WO2004063359A3 Method for producing carotenoids or their precursors using genetically modified organisms of the blakeslea genus, carotenoids or their precursors produced by said method and use thereof
01/27/2005WO2004031730A3 High sensitivity quantitation of peptides by mass spectrometry
01/27/2005WO2004028447A3 Novel compositions and methods for the treatment of psoriasis
01/27/2005WO2004024756A3 Orthopoxvirus antigens and use thereof
01/27/2005WO2003100072A3 Method for the production of sulphur-containing fine chemicals by fermentation
01/27/2005WO2003087374A9 Derivatives of the il-2 receptor gamma chain, their production and use.
01/27/2005WO2003057826A3 SOLUBLE GLcNAC PHOSPHOTRANSFERASE
01/27/2005WO2002042417A3 Human erg2 potassium channel
01/27/2005US20050022269 Expression vector comprising nucleotide sequences coding cartenoid biosynthetic polypeptides for use enhancing cartenoid biosynthesis in darkness
01/27/2005US20050020813 Streptococcus pneumoniae proteins and nucleic acids
01/27/2005US20050020526 Oligodeoxynucleotide intervention for prevention and treatment of sepsis
01/27/2005US20050020514 From fermentation of Streptomyces; bactericides
01/27/2005US20050019931 Nucleic acids encoding antifungal drug targets and methods of use
01/27/2005US20050019925 Transforming cells with vector comprising dihydrofolate reductase marker for use as tool in transfer of heterologous nucleotide sequences
01/27/2005US20050019895 reducing the concentration of methyl tert-butyl ether or tert-amyl methyl ether in ground water, using bacteria on supports; pollution control
01/27/2005US20050019894 used to treat probiotic infectious diarrhea caused by pathogenic microorganisms, gastroenteritis, inflammatory intestinal disease, neurological intestinitis syndrome, overgrowth of small intestinal microorganisms and intestinal feeding diarrhea.
01/27/2005US20050019892 Screening process for antibacterial agents
01/27/2005US20050019889 Human osteoclast derived cathepsin
01/27/2005US20050019887 Mutant nucleic acid; applying to textiles; mixture with metal compound
01/27/2005US20050019886 Generating/designing hydrolase mutants for use in detergents, papermaking and textile treatment
01/27/2005US20050019882 Using plant enzymes for the production of flavor, fragrance, pharmaceutical or bio-control agents from less valuable substrates; terpenoid biosynthesis
01/27/2005US20050019880 Method of enhancing levels of polyunsaturated fatty acids in thraustochytrid protists
01/27/2005US20050019879 Transgenic yeast comprising nucleotide sequences coding L-galactose dehydrogenase (LGDH) for use as enhanced source for generating vitamin c; bioreactor
01/27/2005US20050019877 Genes coding for metabolic pathway proteins
01/27/2005US20050019876 Cellulose produced by filamentous fungi
01/27/2005US20050019872 PC-LECTIN protein; vaccines and diagnostic marker for prostate cancer
01/27/2005US20050019867 Alpha 1,4-galactosyl transferase and DNA encoding thereof
01/27/2005US20050019866 Nucleotide sequences coding membrane protein for use in diagnosis, detection, prevention and/or treatment of cell proliferative disorders
01/27/2005US20050019864 Novel peptide-forming enzyme gene
01/27/2005US20050019858 Novel human cytokine/steroid receptor protein
01/27/2005US20050019857 Expression vector comprising outer membrane protein F (OMPF) regulatory and gene for use as tools in efficient heterologous gene expression; bioreactors
01/27/2005US20050019852 transforming the host cells to express a heterologous, codon-optimized gene encoding a carotene desaturase for the in vivo bioconversion of beta-carotene and/or gamma-carotene into isorenieratene, chlorobactene and/or beta-isorenieratene; Escherichia coli carotene desaturase gene
01/27/2005US20050019835 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
01/27/2005US20050019833 Proteins capable of binding to environmental hormones and process for producing the same
01/27/2005US20050019830 Methods of screening for TRPM5 modulators
01/27/2005US20050019827 Method for unspecific enrichment of bacterial cells
01/27/2005US20050019826 Peptides blocking vascular endothelial growth factor(vegf)-mediated angiogenesis, polynucleotides encoding said pepetides and methods of use thereof
01/27/2005US20050019821 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
01/27/2005US20050019816 Process for producing optically active-4-halo-3-hydroxybutanoate
01/27/2005US20050019814 Pressure-enhanced extraction and purification
01/27/2005US20050019789 Thermostable DNA polymerase from anaerocellum thermophilum
01/27/2005US20050019773 Method for producing and identifying soluble protein domains
01/27/2005US20050019770 Macroporous gel, its preparing and its use
01/27/2005US20050019769 Obtain cells, lyse, separate cell components, resuspended in saline, subjet to enzymatic treatment, precipitate DNA, resuspend in low salt solution
01/27/2005US20050019768 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas
01/27/2005US20050019763 Isolated polypeptide of given sequence; expression vectors, host cells, antibodies, agonists, and antagonists; use in diagnosing, treating, or preventing various disorders
01/27/2005US20050019417 stabilization of proteins, peptides or cells by fluidization of microparticles to form fluidized bed of microparticles comprising water soluble gel forming solid particles, then spraying coating with liquids comprising sugars and solvents, and drying
01/27/2005US20050019346 Nucleic acids and regulatory sequences; gene expression; antitumor agents
01/27/2005US20050019309 Insecticides